Table 2.
Pharmacopoeial names and the number (percentage) of times the names adrenaline and epinephrine have been used in bioscience titles or abstracts since 1965, by country of publication*
| Country of publication | Name in national pharmacopoeia or equivalent | Instances of “adrenalin(e)” | Instances of “epinephrin(e)” |
|---|---|---|---|
| Australia | Adrenaline | 159 (85.0) | 28 (15.0) |
| United Kingdom (England, Northern Ireland, Scotland, Wales) | Adrenaline | 3573 (73.6) | 1 282 (26.4) |
| France | Adrenaline | 453 (69.3) | 201 (30.7) |
| Scandinavia (Denmark, Finland, Norway, Sweden) | Adrenaline† | 710 (68.5) | 327 (31.5) |
| Spain | Epinefrina | 75 (65.2) | 40 (34.8) |
| Italy | Adrenalina | 233 (59.4) | 159 (40.6) |
| Germany | Adrenalinum‡ | 1485 (58.3) | 1 062 (41.7) |
| Rest of the world | — | 3372 (55.4) | 2 214 (36.4) |
| Japan | Epinephrine | 441 (38.1) | 715 (61.9) |
| Canada | Epinephrine | 121 (28.7) | 301 (71.3) |
| United States | Epinephrine | 1157 (9.8) | 10 609 (90.1) |
*
Papers (accessed on Medline) that used both adrenalin(e) and epinephrin(e) were excluded (they comprised under 1% of the total); the Medline records for 1965 are incomplete.
†
No Nordic pharmacopoeia; Scandinavia follows the European Pharmacopoeia.
‡
Deutsches Arzneibuch.